HZNP Stock Topples After J&J Pulls Out Of Bidding War
[ad_1] Johnson & Johnson (JNJ) dropped out of the bidding process for Horizon Therapeutics (HZNP), pushing HZNP stock into the red on Monday. X The decision leaves only Amgen (AMGN)…
[ad_1] Johnson & Johnson (JNJ) dropped out of the bidding process for Horizon Therapeutics (HZNP), pushing HZNP stock into the red on Monday. X The decision leaves only Amgen (AMGN)…
[ad_1] The Food and Drug Administration has a bevy of safety concerns surrounding Verve Therapeutics‘ (VERV) gene-editing approach to high cholesterol, leading VERV stock to crash Monday. X Last month,…
[ad_1] Mirati Therapeutics (MRTX) said almost half of patients responded to its lung cancer regimen, but MRTX stock crashed Tuesday as investors questioned whether it could take on traditional chemotherapy.…
[ad_1] Prometheus Biosciences (RXDX) reported promising results for one of its drugs in two inflammatory disease studies on Wednesday, and RXDX stock catapulted by triple digits. X The company studied…
[ad_1] Entrada Therapeutics (TRDA) inked a $250 million deal with Vertex Pharmaceuticals (VRTX) to develop a muscular dystrophy drug, and the biotech stock surged. X Under the terms of the…